COMPARISON GUIDE
Precision Health Reports vs. Quest CardioIQ: How Do They Compare?
An apples-to-apples comparison of scope, clinical context, and where each option fits best.
Choosing between advanced lab testing and a personalized risk assessment depends on what you need: raw biomarker data or an actionable plan. Below, we compare Precision Health Reports’ Cardiometabolic Risk Assessment with Quest Diagnostics’ CardioIQ.
An Overview of Each Approach
Quest CardioIQ
Quest CardioIQ is an advanced cardiovascular biomarker panel available nationwide through Quest Diagnostics. It provides clinicians with a wide range of blood test options including ApoB, Lp(a), LDL particle analysis, hs-CRP, and more. Most providers can order it as part of their existing Quest workflow, and results are reported with standard lab reference ranges. The strength of CardioIQ is its broad biomarker menu and insurance coverage, but the results require time and expertise to interpret.
Precision Health Reports
Precision Health Reports takes a different approach. Rather than focusing only on lab values, it integrates outcome-proven biomarkers with guideline-based risk models.
Integrates national and international risk-reduction guidelines from ACC, NLA, AHA, AACE, and ESC.
Uses advanced biomarkers such as NMR Lipoprofile measured ApoB, Lp(a), GlycA, hemoglobin A1c, and LP-IR, along with biometrics and clinical history then adjusts for the individual’s age, gender, and ethnicity.
Provides a personalized, clinician-ready report with treatment targets and actionable next steps.
📖 Learn more about our Cardiometabolic Risk Assessment.
Precision Health Reports vs. Quest CardioIQ
| Feature | Precision Health Reports | Quest CardioIQ |
|---|---|---|
| Primary Offering | Cardiometabolic Risk Assessment integrating biomarkers, clinical history, and guideline-based models | Advanced cardiovascular biomarker panel ordered through Quest |
| Clinical History Inputs | Glucose history, smoking status, cardiovascular & lipid history, noninvasive imaging results, autoimmune diseases & confounding conditions | ✗ None (labs only) |
| Physical Exam Inputs | Waist circumference, blood pressure, weight | ✗ None (labs only) |
| Scope of Biomarkers | Lipids, LP-IR Score, ApoB or LDL-P, LDL subfractions, Lp(a), GlycA, Basic Metabolic Panel, and guideline-recommended core labs | Very broad menu to find options including ApoB, Lp(a), LDL subfractions, HDL subfractions, hs-CRP, Lp-PLA2, and more common labs |
| Interpretation | Personalized metabolic risk, diabetic risk, and ASCVD risk calculation with guideline-harmonized treatment goals aligned to major bodies (ACC, AHA, NLA, AACE, ESC). | Lab values with standard reference ranges and optional commentary; interpretation framework is left to the clinician. |
| Actionability | Clear next steps: risk-adjusted LDL-C, non-HDL-C, and ApoB targets for each individual | Data left to the provider to interpret and translate into a care plan |
| Access & Payment | $249 all-in for a full cardiometabolic risk assessment, including clinical history and biometric inputs. | Often insurance-billable, but a comparable self-pay Quest bundle (CardioIQ Advanced Lipid + Insulin Risk + Metabolic Risk + Diabetes Risk) totals $335+ without integrated risk interpretation. |
| Clinical Use Case | Designed for direct primary care, concierge medicine, employer wellness, functional medicine, and preventive cardiology | Broadly used in cardiology and general practice as an add-on advanced lab panel |
Primary Differences between CardioIQ and Precision Health Reports
1. Data vs. Decision Support
CardioIQ delivers detailed biomarker values. including ApoB, Lp(a), LDL particle size, hs-CRP, and moreusing Quest’s nationwide lab infrastructure. The results provide raw data and reference ranges, but it’s up to the provider to interpret what those numbers mean for long-term risk.
Precision Health Reports doesn’t just measure biomarkers; it integrates them into validated risk engines. The report calculates an individual’s metabolic, diabetic, and ASCVD risk, adjusts for ethnicity and clinical history, and overlays guideline-driven thresholds from the ACC, EAS, NLA, MESA, AACE, and others to show exactly where targets should be set.
2. Breadth vs. Relevance
CardioIQ delivers detailed biomarker values—ApoB, Lp(a), LDL particle size, hs-CRP, and more using Quest’s nationwide lab infrastructure. The results provide raw data and reference ranges, but it’s up to the provider to interpret what those numbers mean for long-term risk.
Precision Health Reports doesn’t just measure biomarkers; it integrates them into validated risk engines that are backed by guidelines. The report calculates an individual’s ASCVD risk, adjusts for ethnicity, gender, age and clinical history, and overlays guideline-driven thresholds to show exactly where targets should be for ApoB, LDL-P, LDL-C, and Non-HDL-C.
3. Reporting Style
CardioIQ results look like a traditional lab report: biomarker values, high/low flags, and occasional interpretive notes.
Precision Health Reports produces a narrative risk assessment: it explains a patient’s overall risk, defines personal risk-reduction threshold goals for key biomarkers, and outlines actionable next steps to reduce that risk.
4. Access & Payment
CardioIQ is fully embedded in the traditional healthcare system. It can be ordered through Quest’s existing channels and is sometimes covered by insurance.
Precision Health Reports is typically a cash-pay service, ordered through clinicians or employer wellness programs as well as direct to the individual on the website. While not billable to insurance, orders are almost always eligible for FSA coverage.
5. Clinical Utility
CardioIQ is most useful for cardiologists, lipid specialists, and physicians who are already experienced in interpreting complex lipid and biomarker panels.
Precision Health Reports is built to broaden accessibility. It gives primary care physicians, wellness clinics, and even patients themselves the ability to understand and act on advanced cardiometabolic data without needing subspecialty training.
Which Option Fits Your Needs?
Choose Quest CardioIQ if you're an experienced lipid specialist who needs raw advanced biomarkers and already has an interpretation framework in place.
Choose Precision Health Reports if you want those biomarkers translated into guideline-anchored risk stratification and individualized targets—using clinical history and biometric inputs that materially change the quality of the assessment.
The Bottom Line
Quest CardioIQ is best viewed as an advanced lab panel: powerful for measuring cardiovascular risk factors, but dependent on the clinician to interpret. Precision Health Reports’ Cardiometabolic Risk Assessment is a clinical decision-support tool: it transforms biomarker data and patient history into a personalized risk score and treatment pathway.
Both approaches have value. The choice depends on whether you’re looking for raw data that fits into existing workflows or a risk assessment designed to streamline decision-making and improve patient engagement. Looking for more options? See how Precision Health Reports compares to other testing options on our main comparison page.
👉 Are you a clinician and ready to see how Precision Health Reports can support your clinic or wellness program? Contact us today to learn more.
Take the Next Step
If you are ready to tackle your cardiometabolic disease risk, you can get started right away for just $249/Assessment or use one of our annual subscription models, as low as $35/month. Our Cardiometabolic Risk Assessment gives you a complete picture of your risk for metabolic and cardiovascular disease events with outcome-proven biomarkers and guideline-driven recommendations to give you a clear path forward.
Frequently Asked Questions
-
Quest CardioIQ provides a broad panel of cardiovascular biomarkers. Precision Health Reports interprets those biomarkers within validated risk models and recognized risk-reduction guidelines, creating a personalized risk assessment and treatment plan.
-
No. Both measure outcome-proven biomarkers like ApoB and Lp(a). CardioIQ offers a wider menu, while Precision Health Reports focuses on LabCorp-delivered biomarkers most relevant for clinical decision-making like GlycA and LP-IR and integrates them into guideline-based targets.
-
CardioIQ provides detailed lab data that requires expert interpretation. Precision Health Reports integrates biomarkers individual clinical history and personal details like age, gender, ethnicity, and boimetrics. This results in a narrative report with specific next steps, making it easier for both patients and clinicians to act.
-
CardioIQ is typically covered by insurance and widely available through Quest Diagnostics. Precision Health Reports is a cash-pay service for $249/Assessment (and some multi-test subscription options as low as $35/mo).